Skip to main content

Table 4 Logistic regression model for emphysema

From: Association between plasma sRAGE and emphysema according to the genotypes of AGER gene

  

Univariable

Multivariable

OR (95% CI)

aOR (95% CI)

rs2070600 = CC

 Age

 

1.02 (0.98–1.05)

1.00 (0.96–1.05)

 Sex

Male vs. Female (ref.)

10.04 (4.18–24.12)

5.40 (1.53–19.11)

 Smoking status

Current vs. None (ref.)

5.85 (2.73–12.55)

0.85 (0.27–2.62)

 

Former vs. None (ref.)

7.63 (3.78–15.40)

2.03 (0.73–5.62)

 Income

 ≤ 49 vs. ≥ 100 (ref.)

1.33 (0.72–2.45)

 
 

50–99 vs. ≥ 100 (ref.)

1.74 (0.77–3.89)

 

 Education

 < Elementary vs. high (ref.)

0.38 (0.19–0.77)

 
 

Elementary vs. high (ref.)

0.59 (0.30–1.15)

 
 

Middle vs. high (ref.)

0.46 (0.20–1.10)

 

 BMI

 

0.79 (0.72–0.87)

0.79 (0.70–0.88)

 COPD

Yes vs. No (ref.)

4.39 (2.39–8.06)

2.97 (1.53–5.79)

 Diabetes

Yes vs. No (ref.)

0.65 (0.31–1.38)

 

 Kidney disease

Yes vs. No (ref.)

0.01 (0.001–999.9)

 

 CVD*

Yes vs. No (ref.)

0.71 (0.31–1.61)

 

 Log sRAGE

 

0.23 (0.12–0.44)

0.24 (0.11–0.51)

rs2070600 = TC + TT

 Age

 

1.01 (0.96–1.06)

1.02 (0.95–1.09)

 Sex

Male vs. Female (ref.)

10.00 (0.01–35.82)

5.11 (0.01–21.99)

 Smoking status

Current vs. None (ref.)

10.54 (2.88–38.57)

1.54 (0.33–7.14)

 

Former vs. None (ref.)

10.41 (3.33–32.54)

1.65 (0.42–6.41)

 Income

 ≤ 49 vs. ≥ 100 (ref.)

0.38 (0.15–0.97)

 
 

50–99 vs. ≥ 100 (ref.)

0.46 (0.14–1.52)

 

 Education

 < Elementary vs. high (ref.)

0.10 (0.03–0.36)

 
 

Elementary vs. high (ref.)

0.29 (0.11–0.77)

 
 

Middle vs. high (ref.)

0.79 (0.21–3.03)

 

 BMI

 

0.77 (0.67–0.88)

0.77 (0.65–0.91)

 COPD

Yes vs. No (ref.)

6.27 (2.43–16.20)

4.46 (1.58–12.58)

 Diabetes

Yes vs. No (ref.)

1.01 (0.41–2.51)

 

 Kidney disease

Yes vs. No (ref.)

4.00 (0.85–18.88)

 

 CVD

Yes vs. No (ref.)

0.47 (0.15–1.47)

 

 Log sRAGE

 

0.77 (0.35–1.70)

0.61 (0.23–1.61)

  1. OR, odds ratio; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; sRAGE, soluble receptor for advanced glycation end product